
OHI Stock Forecast & Price Target
OHI Analyst Ratings
Bulls say
Omega Healthcare Invts is viewed positively because it has shown stronger capital deployment, completing about $1.5 billion of deals year to date and using creative structures that should support better risk-adjusted returns and roughly $0.10/share of annualized AFFO accretion. The company’s opportunistic portfolio actions, including operator transitions, lease restructurings, and asset sales, have improved lease coverage and are aligned with a higher-growth mix in SNFs, SHOP, and UK care homes. Its balance sheet also remains solid, with pro-forma net debt to EBITDA in the mid-3.0x range and estimates rising to $3.30/share in 2026, $3.40/share in 2027, and $3.58/share in 2028, supporting the constructive outlook.
Bears say
Omega Healthcare Invts is facing a negative setup because a difficult skilled nursing facility environment, potentially worsened by Medicaid cuts, could pressure tenants and slow new investment activity. The excerpt also highlights that the stock could rerate to an 11x multiple if AFFO run-rate merely holds near 2026 levels, suggesting limited upside support and vulnerability to valuation compression. More broadly, the cautious stance reflects weak near-term catalysts, uncertainty around operator health, and an environment where even depressed valuations have not yet translated into a durable fundamental recovery.
This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Omega Healthcare Investors (OHI) Forecast
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares